Rehmann Capital Advisory Group’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$77.4K Hold
2,111
0.01% 513
2019
Q2
$98.2K Hold
2,111
0.01% 618
2019
Q1
$84.8K Hold
2,111
0.01% 644
2018
Q4
$97.1K Buy
+2,111
New +$97.1K 0.01% 409